By January 2026, India has fully operationalized a robust National Pharmacovigilance Program for Ayurvedic products. This system is designed to dismantle the myth that "natural" always means "safe" by documenting and analyzing adverse drug reactions (ADRs).

Structure of the Safety Network

1. NPvCC (National Pharmacovigilance Centre): Located at the All India Institute of Ayurveda (AIIA), New Delhi, which coordinates the entire country's data.

2. Intermediary Centres (IPvCCs): Regional hubs that manage data from specific geographic zones.

3. Peripheral Centres (PPvCCs): Individual Ayurvedic hospitals and colleges where patients and doctors report incidents directly. This network also monitors "misleading advertisements" in digital and print media, taking regulatory action against products that make unverified "magic cure" claims.